Telomir Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Telomir Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) (NCT07581314) | Telomir Pharmaceuticals, Inc. | 2026-10-01 |
Track Telomir Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.